Clover Health Investments Corp. Shs A Unsponsored Brazilian Depositary Receipt Repr 1 Sh A(BR:CLOV34)
R$27.69+0.45 (+1.65%)
BR:CLOV34
Clover Health Investments Corp. Shs A Unsponsored Brazilian Depositary Receipt Repr 1 Sh A earnings date
R$27.69
At close:+0.45 (+1.65%)
Clover Health Investments Corp. Shs A Unsponsored Brazilian Depositary Receipt Repr 1 Sh A (CLOV34) Q2 2025 Earnings Report
BR:CLOV34 Q2 2025 EPS Results
- Actual EPS
- BRL 0.00
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- BRL 0.00
BR:CLOV34 Q2 2025 Revenue Results
- Actual Revenue
- BRL 2.71B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +45.85%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/05/2025
- Time
- After Close
- Conference Call
- Tuesday, August 5, 2025
BR:CLOV34 Upcoming Earnings
Clover Health Investments Corp. Shs A Unsponsored Brazilian Depositary Receipt Repr 1 Sh A's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
BR:CLOV34 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | ―- | 0 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | ―0.00 | 0 | ― | |
| Aug 05, 2026 | 2026 (Q2) | ―0.00 | 0 | ― | |
| May 06, 2026 | 2026 (Q1) | ―0.00 | 0 | ― | |
| Feb 26, 2026 | 2025 (Q4) | ―-0.00 | 0 | ― | |
| Nov 04, 2025 | 2025 (Q3) | ―0.00 | 0 | ― | |
| Aug 05, 2025 | 2025 (Q2) | ―0.00 | 0 | ― | |
| May 06, 2025 | 2025 (Q1) | ―0.00 | 0 | ― | |
| Feb 27, 2025 | 2024 (Q4) | ―0.00 | 0 | 100.00% (+0.00) | |
| Nov 06, 2024 | 2024 (Q3) | ―0.00 | 0 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
